Nautilus Biotechnology Inc. Common Stock (NAUT)
Stock · NASDAQ · Industrials
$2.06as of 10/16/2026
Price chart
Active signals
NAUT Signal Track Record
How signals performed across all stocks →What NAUT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 41 | -2.2% | 39% | September 28, 2026 |
| Bollinger Band Breakout | 24 | -1.9% | 33% | September 28, 2026 |
| Bollinger Band Breakdown | 17 | -2.5% | 41% | July 28, 2026 |
| 200-Day Moving Average TouchActive now | 12 | -1.1% | 42% | October 25, 2024 |
| Any 20-session window (baseline) | -1.9% | 45% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NAUT
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution op…
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Employees
- 127
- Website
- www.nautilus.bio
Fundamentals
- 1-day range
- $1.88$2.2
- Market cap
- $112.76M
- P/E (trailing)
- —
- P/E (forward)
- -2.92
- EPS (trailing)
- $-0.45
- Dividend yield
- —
- Beta
- 0.78
- Avg. volume
- 3.41M
Forecasts
3 analyst ratings
Nautilus Biotechnology Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- NAUTNautilus Biotechnology Inc. Common Stock$2.06▼ 4.63%Market cap $112.76MP/E —$0.8399$4.31
- SEERSeer Inc. Class A Common Stock$2.03▼ 0.49%Market cap $120.41MP/E —$1.55$2.41
- RPIDRapid Micro Biosystems Inc. Class A Common Stock$0.764▼ 9.59%Market cap $96.03MP/E —$0.8087$4.94
- CIRCCircle8 Group Inc. Common Stock$0.302▼ 5.33%Market cap $70.73MP/E —$0.3132$0.98
- QTRXQuanterix Corporation Common Stock$2.87▼ 6.51%Market cap $180.42MP/E —$2.15$8.77
- PRPOPrecipio Inc. Common Stock$21.38▼ 5.17%Market cap $41.93MP/E —$16.4$33.63
- HBIOHarvard Bioscience Inc. Common Stock$8.09▼ 2.65%Market cap $27.92MP/E —$3.75$9.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NAUT Nautilus Biotechnology Inc. Common Stock | $112.76M | — | $2.06 | ▼ 4.63% | $0.8399$4.31 |
| SEER Seer Inc. Class A Common Stock | $120.41M | — | $2.03 | ▼ 0.49% | $1.55$2.41 |
| RPID Rapid Micro Biosystems Inc. Class A Common Stock | $96.03M | — | $0.764 | ▼ 9.59% | $0.8087$4.94 |
| CIRC Circle8 Group Inc. Common Stock | $70.73M | — | $0.302 | ▼ 5.33% | $0.3132$0.98 |
| QTRX Quanterix Corporation Common Stock | $180.42M | — | $2.87 | ▼ 6.51% | $2.15$8.77 |
| PRPO Precipio Inc. Common Stock | $41.93M | — | $21.38 | ▼ 5.17% | $16.4$33.63 |
| HBIO Harvard Bioscience Inc. Common Stock | $27.92M | — | $8.09 | ▼ 2.65% | $3.75$9.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- These stocks are moving in today's sessionChartMill · 10/9/2026
- Let's have a look at the top gainers and losers in the middle of the day of today's session.ChartMill · 10/9/2026
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · 10/9/2026
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga · 10/7/2026
- These stocks have an unusual volume in today's sessionChartMill · 10/6/2026
- Curious about the stocks that are showing activity after the closing bell on Friday?ChartMill · 10/2/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 10/2/2026
- Voyager Will Take Center Stage In Nautilus' Commercial PushSeekingAlpha · 10/1/2026
- This SpaceX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesdaybenzinga · 9/29/2026
Insider Activity
Insider Actions →- McIlwain Matthew S · June 18, 2026 · Grant45.0K
- NAZEM FARZAD · June 18, 2026 · Grant45.0K
- Epperly Melissa B, · June 18, 2026 · Grant45.0K
- Akinsanya Karen · June 18, 2026 · Grant45.0K
- Matthew L. Posard · June 18, 2026 · Grant45.0K
- Marc L. Andreessen · June 2, 2026 · Sale384.0K @ $2.35
- Marc L. Andreessen · June 2, 2026 · Sale4.62M @ $2.35
Institutional Ownership
March 31, 2026
- Total shares held
- 54.08M
- Total value held
- $203.14M
- Institutional holders
- 81
- Unknown17.65M
- Unknown12.59M
- Unknown7.17M
- Unknown2.55M
- Unknown2.33M
- Unknown2.21M
- Unknown1.46M
- Unknown1.27M
- Unknown750.0K
- Unknown741.2K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Roth Capital initiates coverage on NAUT with $3.50 target
Roth Capital began tracking Nautilus Biotechnology with a Buy rating and a price target of $3.50. This new analyst note adds to the current consensus, where the average target from two analysts is $4.00. The stock is currently trading within its 52-week range of $0.72 to $4.31.
Roth Capital initiates coverage on NAUT with $3.50 target. Roth Capital began tracking Nautilus Biotechnology with a Buy rating and a price target of $3.50. This new analyst note adds to the current consensus, where the average target from two analysts is $4.00. The stock is currently trading within its 52-week range of $0.72 to $4.31.